Market Research Logo

Global B-cell non hodgkin lymphoma drugs market 2018-2022

Global B-cell non hodgkin lymphoma drugs market 2018-2022

About B-Cell Non-Hodgkin Lymphoma Drugs

B-cell non-Hodgkin lymphoma (NHL) is a type of cancer that forms in B-cells. It may be either indolent (slow-growing) or aggressive (fast-growing). Most B-cell lymphomas are non-Hodgkin lymphomas. There are various types of B-cell NHL including Burkitt lymphoma, chronic lymphocytic leukemia (CLL), follicular lymphoma, and mantle cell lymphoma.

Technavio’s analysts forecast the Global B-Cell Non-Hodgkin Lymphoma Drugs Market to grow at a CAGR of 7.52% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the B-cell non-Hodgkin lymphoma drugs market. To calculate the market size, the report considers the revenue generated from the retail sales of B-cell non-Hodgkin lymphoma drugs across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, B-cell non-Hodgkin lymphoma drugs market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Biogen
  • F. Hoffmann-La Roche
  • Merck
  • Novartis
  • Spectrum Pharmaceuticals
Market driver
  • Growing government initiatives
  • For a full, detailed list, view our report
Market challenge
  • High cost of treatment
  • For a full, detailed list, view our report
Market trend
  • Strong pipeline
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global NHL therapeutics market segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition: Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast
      • Table Global B-cell NHL drugs market 2017-2022 ($ mn)
      • Table Global B-Cell NHL drugs market: Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition: Five forces 2017
  • Pipeline landscape
    • Table Pipeline landscape by development phase
    • Table Late stage pipeline molecules of B-cell NHL
  • Market segmentation by category
    • Segmentation by category
      • Table Global B-cell NHL drugs market - Market share by category 2017-2022 (%)
    • Comparison by category
      • Table Comparison by category
    • Small molecules - Market size and forecast 2017- 2022
      • Table Global B-cell NHL drugs market by small molecules 2017-2022 ($ mn)
      • Table Global B-cell NHL drugs market by small molecules: Year-over-year growth 2018-2022 (%)
    • Biologicals - Market size and forecast 2017-2022
      • Table Global B-cell NHL drugs market by biologicals 2017-2022 ($ mn)
      • Table Global B-cell NHL drugs market by biologicals: Year-over-year growth 2018-2022 (%)
    • Market opportunity by category
      • Table Market opportunity by category
  • Regional landscape
    • Geographical segmentation
      • Table Global B-cell NHL drugs market by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • B-cell NHL drugs market in Americas
      • Table B-cell NHL drugs market in Americas 2017-2022 ($ mn)
      • Table B-cell NHL drugs market in Americas: Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • B-cell NHL drugs market in EMEA
      • Table B-cell NHL drugs market in EMEA 2017-2022 ($ mn)
      • Table B-cell NHL drugs market in EMEA: Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • B-cell NHL drugs market in APAC
      • Table B-cell NHL drugs market in APAC 2017-2022 ($ mn)
      • Table B-cell NHL drugs market in APAC: Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Customer landscape
    • Table Customer landscape
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Strong pipeline
    • Strategic alliances
    • Advanced technologies
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Biogen
      • Table Biogen - Overview
      • Table Biogen - Business segments
      • Table Biogen - Organizational developments
      • Table Biogen - Geographic focus
      • Table Biogen - Segment focus
      • Table Biogen - Key offerings
      • Table Biogen - Key customers
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche - Overview
      • Table F. Hoffmann-La Roche - Business segments
      • Table F. Hoffmann-La Roche - Organizational developments
      • Table F. Hoffmann-La Roche - Geographic focus
      • Table F. Hoffmann-La Roche - Segment focus
      • Table F. Hoffmann-La Roche - Key offerings
      • Table F. Hoffmann-La Roche - Key customers
    • Merck
      • Table Merck - Overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
      • Table Merck - Key customers
    • Novartis
      • Table Novartis - Overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
      • Table Novartis - Key customers
    • Spectrum Pharmaceuticals
      • Table Spectrum Pharmaceuticals - Overview
      • Table Spectrum Pharmaceuticals - Business segments
      • Table Spectrum Pharmaceuticals - Organizational developments
      • Table Spectrum Pharmaceuticals - Geographic focus
      • Table Spectrum Pharmaceuticals - Segment focus
      • Table Spectrum Pharmaceuticals - Key offerings
      • Table Spectrum Pharmaceuticals - Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report